ESSEX WOODLANDS HEALTH VENTURES FUND V LP 3
3 · ACURA PHARMACEUTICALS, INC · Filed Oct 4, 2004
Insider Transaction Report
Form 3
ACURA PHARMACEUTICALS, INCACUR.OB
Holdings
- 114,477
Common Stock
Series A Preferred Stock
From: 2004-08-13→ Common Stock (33,909,751 underlying)Series B Preferred Stock
From: 2004-08-13→ Common Stock (6,756,207 underlying)Series C-3 Preferred Stock
From: 2004-08-13→ Common Stock (15,593,247 underlying)Common Stock Purchase Warrant
Exercise: $0.34From: 2003-05-08Exp: 2010-05-08→ Common Stock (345,000 underlying)
Footnotes (3)
- [F1]Shares of the issuer's Preferred Stock are convertible into shares of the issuer's Common Stock for as long as such shares are outstanding.
- [F2]Shares of the issuer's Series A Preferred Stock currently are convertible into shares of the issuer's Common Stock on a 5-for-1 basis.
- [F3]Shares of the issuer's Series B Preferred Stock and Series C-3 Preferred Stock currently are convertible into shares of the issuer's Common Stock on a 1-for-1 basis.